141 related articles for article (PubMed ID: 7114924)
1. Natural killer cell activity in untreated systemic lupus erythematosus.
Oshimi K; Sumiya M; Gonda N; Kano S; Takaku F
Ann Rheum Dis; 1982 Aug; 41(4):417-20. PubMed ID: 7114924
[TBL] [Abstract][Full Text] [Related]
2. Natural killer augmentation in systemic lupus erythematosus via a soluble mediator derived from human lymphocytes.
Kaufman DB
Arthritis Rheum; 1982 May; 25(5):562-7. PubMed ID: 7082401
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cell activity in systemic lupus erythematosus.
Oshimi K; Sumiya M; Gonda N; Kano S; Takaku F
Lancet; 1979 Nov; 2(8150):1023. PubMed ID: 91760
[No Abstract] [Full Text] [Related]
4. Effects of corticosteroids on natural killer cell activity in systemic lupus erythematosus.
Oshimi K; Gonda N; Sumiya M; Kano S
Clin Exp Immunol; 1980 Apr; 40(1):83-8. PubMed ID: 7389219
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.
Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083
[TBL] [Abstract][Full Text] [Related]
6. [In vitro augmentation of human natural killer cell activity by pokeweed mitogen-stimulated lymphocytes].
Matsumoto Y; Katoh Y
Rinsho Byori; 1983 Oct; 31(10):1122-6. PubMed ID: 6674584
[No Abstract] [Full Text] [Related]
7. Natural and antibody-dependent cellular cytotoxicity in children with systemic lupus erythematosus and juvenile dermatomyositis.
Miller ML; Lantner R; Pachman LM
J Rheumatol; 1983 Aug; 10(4):640-2. PubMed ID: 6620266
[TBL] [Abstract][Full Text] [Related]
8. Defective natural killer (NK) and killer (K) cell function in systemic lupus erythematosus.
Ewan PW; Barrett HM; Pusey CD
J Clin Lab Immunol; 1983 Feb; 10(2):71-6. PubMed ID: 6842577
[TBL] [Abstract][Full Text] [Related]
9. [Effects of Astragalus membranaceus and Tripterygium hypoglancum on natural killer cell activity of peripheral blood mononuclear in systemic lupus erythematosus].
Zhao XZ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1992 Nov; 12(11):669-71, 645. PubMed ID: 1301849
[TBL] [Abstract][Full Text] [Related]
10. Depressed natural and lectin-dependent cell-mediated cytotoxicity against adherent HEp-2 cells in patients with systemic lupus erythematosus.
Perl A; Gonzalez-Cabello R; Láng I; Gergely P
Immunol Commun; 1982; 11(6):431-40. PubMed ID: 7169224
[TBL] [Abstract][Full Text] [Related]
11. [Natural cytotoxicity in systemic lupus erythematosus patients].
Aleksandrova EN; Nasonov EL; Bykhovskaia SIu; Ivanova MM; Solov'ev SK
Ter Arkh; 1984; 56(5):29-32. PubMed ID: 6463883
[No Abstract] [Full Text] [Related]
12. Effects of ultraviolet irradiation on natural killer cell function in systemic lupus erythematosus.
Nived O; Johansson I; Sturfelt G
Ann Rheum Dis; 1992 Jun; 51(6):726-30. PubMed ID: 1616354
[TBL] [Abstract][Full Text] [Related]
13. Recent findings on the role of natural killer cells in the pathogenesis of systemic lupus erythematosus.
Spada R; Rojas JM; Barber DF
J Leukoc Biol; 2015 Oct; 98(4):479-87. PubMed ID: 26216938
[TBL] [Abstract][Full Text] [Related]
14. Abnormal interferon modulation of natural cytotoxicity in systemic lupus erythematosus. Relation to suppressive serum factors.
Sibbitt WL; Froelich CJ; Bankhurst AD
Arthritis Rheum; 1983 Dec; 26(12):1452-9. PubMed ID: 6651894
[TBL] [Abstract][Full Text] [Related]
15. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of natural killer cell activity by serum from patients with systemic lupus erythematosus: roles of disease activity and serum interferon.
Ytterberg SR; Schnitzer TJ
Ann Rheum Dis; 1984 Jun; 43(3):457-61. PubMed ID: 6204601
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and functional analysis of natural killer cells in systemic lupus erythematosus patients.
Chiang BL; Chen YC; Wang CR; Lin YL; Chou CC; Hsieh KH
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(5):357-63. PubMed ID: 8607362
[TBL] [Abstract][Full Text] [Related]
18. Insensitivity to interferon of NK cells from patients with systemic lupus erythematosus.
Fitzharris P; Alcocer J; Stephens HA; Knight RA; Snaith ML
Clin Exp Immunol; 1982 Jan; 47(1):110-8. PubMed ID: 6178542
[TBL] [Abstract][Full Text] [Related]
19. Interferons and systemic lupus erythematosus.
Bankhurst AD
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():63-7. PubMed ID: 2441046
[TBL] [Abstract][Full Text] [Related]
20. [Circulating immune complexes and NK activity in systemic lupus erythematosus].
Haas H; Havel A; Lange A; Gross W; Flad HD; Schlaak M
Immun Infekt; 1984 Apr; 12(2):109-10. PubMed ID: 6534842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
